Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Human TAFA3/FAM19A3 Recombinant Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.
Manufacturer: R&D Systems™ 4677TA050
This item is not returnable.
View return policy
Description
The Recombinant Human TAFA3/FAM19A3 Protein has been validated for the following applications: Bioactivity.Specifications
| Q7Z5A8 | |
| 284467 | |
| TAFA3/FAM19A3 | |
| 95%, by SDS-PAGE with silver staining | |
| 50μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Ala31 | |
| Unconjugated |
| Lyophilized from a 0.2μm filtered solution in PBS | |
| 11kDa | |
| Reconstitute at 400μg/mL in sterile PBS. | |
| SDS-PAGE: 10kDa, reducing conditions | |
| E. coli-derived human TAFA3/FAM19A3 protein Ala31-Arg133 | |
| RUO | |
| Carrier Protein | |
| Yes |
Safety and Handling
ShelfLife : 365 days
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title